相关实验视频

Updated: May 5, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

贝图林酸用于质母细胞瘤治疗:现实,挑战和前景

Sílvia Fernandes^1,2, Mariana Vieira¹, Cristina Prudêncio^1,3

¹Center for Translational Health and Medical Biotechnology Research (TBIO), School of Health (ESS), Polytechnic University of Porto, Rua Dr. António Bernardino de Almeida, 400, 4200-072 Porto, Portugal.

International journal of molecular sciences

|February 24, 2024

概括

贝图林酸作为抗瘤药物表现有前途,特别是在质母细胞瘤中. 它穿越血脑屏障并选择性杀死癌细胞的能力为治疗提供了新的途径.

科学领域:

自然产品化学化学
在瘤学瘤学.
神经科学是一个神经科学.

背景情况:

贝图林酸是一种天然衍生化合物,具有多种药理学活性,包括抗炎,抗病毒,抗疟和抗氧化性质.
它穿透血脑屏障的能力对于治疗神经疾病至关重要.

研究的目的:

审查贝鲁林酸的抗瘤作用,重点关注其对抗质母细胞瘤的应用.
探索其作用机制和临床转化潜力.

主要方法:

对研究贝鲁林酸对抗质母细胞瘤的疗效和机制的文献综述.
分析其对质母细胞瘤细胞增殖,细胞亡和信号通路的影响.

主要成果:

贝图林酸对质母细胞瘤细胞具有选择性的抗瘤活性,抑制其增殖并诱导亡.
它抑制了Akt/NFκB-p65信号级联,并增强了temozolomide的细胞毒性.
贝图林酸调节了导致质母细胞瘤侵袭性和攻击性的因素.

结论:

贝图林酸是一种强大的抗瘤药物,可以对抗质母细胞瘤,通过多种途径起作用.
氨酸的纳米粒子和离子液体配方显示出在质母细胞瘤治疗中临床应用的潜力.

关键词:

灭症 (apoptosis) 是一种死亡的过程.贝鲁利尼克酸是什么意思血脑屏障血脑屏障血脑屏障血脑屏障药物输送是药物输送的过程.质母细胞瘤 (glioblastoma) 是一种侵入性侵袭性侵袭性

更多相关视频

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...